NASDAQ | ETF
The fund will invest primarily in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies which the adviser believes are leaders and where the magnitude and/or duration of future growth for these companies is underappreciated by the market.
Under normal circumstances, the fund invests at least 80% of its assets in the equity securities of healthcare companies.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 8.04% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 7.20% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 7.06% |
| NOVO-B | Novo Nordisk A/S | Healthcare | Biotechnology | 5.56% |
| AZN | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 4.76% |
| ROG | Roche Holding AG | Healthcare | Drug Manufacturers - General | 4.17% |
| BSX | Boston Scientific Corp | Healthcare | Medical Devices | 3.28% |
| UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 3.24% |
| SYK | Stryker Corporation | Healthcare | Medical Devices | 3.05% |
| MDT | Medtronic PLC | Healthcare | Medical Devices | 3.02% |
| DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 2.99% |
| CVS | CVS Health Corp | Healthcare | Healthcare Plans | 2.81% |
| ARGX | Argen-X | Healthcare | Biotechnology | 2.44% |
| VEEV | Veeva Systems Inc Class A | Healthcare | Health Information Services | 2.38% |
| MCK | McKesson Corporation | Healthcare | Medical Distribution | 2.36% |
| EL | EssilorLuxottica S. A. | Healthcare | Medical Instruments & Supplies | 2.22% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 2.18% |
| SAN | Sanofi SA | Healthcare | Drug Manufacturers - General | 2.05% |
| LONN | Lonza Group AG | Healthcare | Diagnostics & Research | 2.02% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 1.80% |